Research and Markets: Global Acute Myeloid Leukemia Epidemiology and Patient Flow Analysis 2015

<0> Research and Markets: Global Acute Myeloid Leukemia Epidemiology and Patient Flow Analysis 2015 </0>

<0> Research and MarketsLaura Wood, Senior ManagerFor E.S.T Office Hours Call 1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT Office Hours Call +353-1-416-8900U.S. Fax: 646-607-1907Fax (outside U.S.): +353-1-481-1716Sector: </0>

() has announced the addition of the report to their offering.

The report provides insights into Acute Myeloid Leukemia epidemiology, Acute Myeloid Leukemia diagnosed patients, and Acute Myeloid Leukemia treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Acute Myeloid Leukemia derived from epidemiological analysis, percentage of patients diagnosed with Acute Myeloid Leukemia, and percentage of patients treated with Acute Myeloid Leukemia therapy.

The study helps executives estimate Acute Myeloid Leukemia market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Acute Myeloid Leukemia prevalence, Acute Myeloid Leukemia diagnosis rate, and Acute Myeloid Leukemia treatment rate for the period 2014 - 2020. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan.

1. Acute Myeloid Leukemia: Disease Definition

2. Global Acute Myeloid Leukemia Patient Flow

3. Acute Myeloid Leukemia Patient Flow in the US

4. Acute Myeloid Leukemia Patient Flow in Europe

5. Acute Myeloid Leukemia Patient Flow in Germany

6. Acute Myeloid Leukemia Patient Flow in France

7. Acute Myeloid Leukemia Patient Flow in Spain

8. Acute Myeloid Leukemia Patient Flow in Italy

9. Acute Myeloid Leukemia Patient Flow in UK

10. Acute Myeloid Leukemia Patient Flow in Japan

11. Appendix

For more information visit

On-Demand Webinar

Leveraging A Medical Record-Enriched Patient Dataset for COVID-19 Research

You are invited to join a webinar that will explore the ways researchers can leverage this enriched dataset for important COVID-19 research. Sign up today for this informative webinar to learn how you can leverage one of the only medical record reviews solely using real-world data from hospitalized COVID-19 patients.

Suggested Articles

Life sciences companies have pivoted quickly during COVID-19 - Syneos Health® is supporting more than 80 active COVID-19 projects, including vaccines.

New York's Covaxx has signed on with three South American nations to provide 140 million doses of its early-stage COVID-19 vaccine.

To get the COVID-19 vaccine out quickly, Pfizer has been running rehearsals at distribution sites, creating "growing confidence," U.S. officials said.